Atalanta Sosnoff Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-57,260
Closed -$29M 104
2023
Q3
$29M Sell
57,260
-58,694
-51% -$31.3M 0.86% 46
2023
Q2
$60.5M Sell
115,954
-4,662
-4% -$2.52M 1.64% 17
2023
Q1
$69.5M Buy
120,616
+59,311
+97% +$33.4M 2.02% 13
2022
Q4
$33.8M Buy
+61,305
New +$32.5M 1.04% 39
2020
Q4
Sell
-15,223
Closed -$6.72M 109
2020
Q3
$6.72M Sell
15,223
-14,619
-49% -$6.04M 0.19% 72
2020
Q2
$10.8M Buy
29,842
+14,117
+90% +$4.73M 0.33% 60
2020
Q1
$4.46M Buy
15,725
+12,140
+339% +$3.83M 0.16% 70
2019
Q4
$1.17M Sell
3,585
-5
-0.1% -$1.52K 0.03% 71
2019
Q3
$1.05M Hold
3,590
0.03% 68
2019
Q2
$1.05M Sell
3,590
-1,645
-31% -$453K 0.03% 69
2019
Q1
$1.43M Buy
5,235
+3,040
+138% +$757K 0.04% 64
2018
Q4
$491K Hold
2,195
0.02% 70
2018
Q3
$536K Buy
+2,195
New +$505K 0.02% 64
2015
Q2
Sell
-296,760
Closed -$39.9M 110
2015
Q1
$39.9M Sell
296,760
-16,335
-5% -$2.11M 1.06% 45
2014
Q4
$39.2M Sell
313,095
-14,288
-4% -$1.74M 0.97% 48
2014
Q3
$39.8M Buy
+327,383
New +$39.8M 0.99% 44

Other funds holding TMO

Atalanta Sosnoff Capital's TMO Position: Q4 2023 in Review

Atalanta Sosnoff Capital sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 57,260 shares — an estimated $29M sold.

Atalanta Sosnoff Capital first reported a position in TMO in Q3 2014 and held it in 16 quarters. The position peaked at $69.5M in Q1 2023. 2,490 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

  • Atalanta Sosnoff Capital reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
  • Atalanta Sosnoff Capital sold 57,260 Thermo Fisher Scientific shares in Q4 2023, an estimated $29M.
  • Atalanta Sosnoff Capital first reported a position in Thermo Fisher Scientific in Q3 2014 and held it in 16 quarters.
  • Atalanta Sosnoff Capital's Thermo Fisher Scientific position peaked at $69.5M in Q1 2023.
  • 2,490 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Atalanta Sosnoff Capital's 13F filing for Q4 2023, filed 12 Feb 2024.